Showing results (21-30 of 76) with videos related to

Sort By:
Pageof 8
Neuroscience Letters|March 6, 2013
DBH gene as predictor of response in a cocaine vaccine clinical trialThomas R Kosten, Coreen B Domingo, Sara C Hamon, et al.
Psychiatry Research|January 13, 2018
Impact of synthetic cannabinoid use on hospital stay in patients with bipolar disorder versus schizophrenia, or other psychotic disordersHuiqiong Deng, Satyajit Mohite, Robert Suchting, et al.
Pharmacological Reviews|March 1, 2005
Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatmentsMary Jeanne Kreek, Gavin Bart, Charles Lilly, et al.
The American Journal on Addictions|June 20, 2023
Promoter region variant C-824T in the TH gene modulates the subjective effects of cocainePeter K Bolin, Ellen M Nielsen, David A Nielsen, et al.
Pharmacogenomics|August 23, 2012
Epigenetics of drug abuse: predisposition or responseDavid A Nielsen, Amol Utrankar, Jennifer A Reyes, et al.
Pharmacogenetics and Genomics|May 3, 2013
ANKK1 and DRD2 pharmacogenetics of disulfiram treatment for cocaine abuseCatherine J Spellicy, Thomas R Kosten, Sara C Hamon, et al.
Psychiatric Genetics|July 7, 2015
Addiction pharmacogenetics: a systematic review of the genetic variation of the dopaminergic systemMichelle A Patriquin, Isabelle E Bauer, Jair C Soares, et al.
Neuroimage|October 21, 2015
Integrative Bayesian analysis of neuroimaging-genetic data with application to cocaine dependenceShabnam Azadeh, Brian P Hobbs, Liangsuo Ma, et al.
Frontiers in Psychiatry|January 22, 2013
The MTHFR C677T Variant is Associated with Responsiveness to Disulfiram Treatment for Cocaine DependencyCatherine J Spellicy, Thomas R Kosten, Sara C Hamon, et al.
Behavior Genetics|January 9, 2008
TPH2 and TPH1: association of variants and interactions with heroin addictionDavid A Nielsen, Sandra Barral, Dmitri Proudnikov, et al.
Pageof 8